PAHC vs. BSX
Compare and contrast key facts about Phibro Animal Health Corporation (PAHC) and Boston Scientific Corporation (BSX).
Performance
PAHC vs. BSX - Performance Comparison
Loading graphics...
PAHC vs. BSX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PAHC Phibro Animal Health Corporation | 46.91% | 80.76% | 86.30% | -10.42% | -32.33% | 7.28% | -20.09% | -21.31% | -3.00% | 15.75% |
BSX Boston Scientific Corporation | -34.98% | 6.75% | 54.51% | 24.94% | 8.92% | 18.16% | -20.50% | 27.96% | 42.56% | 14.61% |
Fundamentals
PAHC:
$2.24B
BSX:
$92.74B
PAHC:
$2.25
BSX:
$1.93
PAHC:
24.29
BSX:
32.07
PAHC:
0.06
BSX:
0.72
PAHC:
1.53
BSX:
4.62
PAHC:
6.75
BSX:
3.83
PAHC:
$1.46B
BSX:
$20.08B
PAHC:
$467.02M
BSX:
$13.85B
PAHC:
$209.00M
BSX:
$4.91B
Returns By Period
In the year-to-date period, PAHC achieves a 46.91% return, which is significantly higher than BSX's -34.98% return. Over the past 10 years, PAHC has underperformed BSX with an annualized return of 9.42%, while BSX has yielded a comparatively higher 12.59% annualized return.
PAHC
- 1D
- -0.99%
- 1M
- 0.63%
- YTD
- 46.91%
- 6M
- 34.89%
- 1Y
- 152.57%
- 3Y*
- 56.73%
- 5Y*
- 19.98%
- 10Y*
- 9.42%
BSX
- 1D
- -1.20%
- 1M
- -18.66%
- YTD
- -34.98%
- 6M
- -35.32%
- 1Y
- -38.76%
- 3Y*
- 7.41%
- 5Y*
- 9.95%
- 10Y*
- 12.59%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PAHC vs. BSX — Risk / Return Rank
PAHC
BSX
PAHC vs. BSX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Phibro Animal Health Corporation (PAHC) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PAHC | BSX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 2.90 | -1.24 | +4.14 |
Sortino ratioReturn per unit of downside risk | 3.81 | -1.64 | +5.46 |
Omega ratioGain probability vs. loss probability | 1.47 | 0.75 | +0.72 |
Calmar ratioReturn relative to maximum drawdown | 6.45 | -0.90 | +7.36 |
Martin ratioReturn relative to average drawdown | 17.51 | -2.54 | +20.05 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| PAHC | BSX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.90 | -1.24 | +4.14 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.45 | 0.41 | +0.03 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.22 | 0.47 | -0.26 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.29 | 0.22 | +0.07 |
Correlation
The correlation between PAHC and BSX is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
PAHC vs. BSX - Dividend Comparison
PAHC's dividend yield for the trailing twelve months is around 0.88%, while BSX has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PAHC Phibro Animal Health Corporation | 0.88% | 1.28% | 2.29% | 4.15% | 3.58% | 2.35% | 2.47% | 1.93% | 1.31% | 1.19% | 1.37% | 1.33% |
BSX Boston Scientific Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
PAHC vs. BSX - Drawdown Comparison
The maximum PAHC drawdown since its inception was -79.62%, smaller than the maximum BSX drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for PAHC and BSX.
Loading graphics...
Drawdown Indicators
| PAHC | BSX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -79.62% | -89.15% | +9.53% |
Max Drawdown (1Y)Largest decline over 1 year | -24.52% | -42.67% | +18.15% |
Max Drawdown (5Y)Largest decline over 5 years | -65.71% | -42.67% | -23.04% |
Max Drawdown (10Y)Largest decline over 10 years | -79.62% | -43.49% | -36.13% |
Current DrawdownCurrent decline from peak | -3.95% | -42.67% | +38.72% |
Average DrawdownAverage peak-to-trough decline | -39.24% | -38.71% | -0.53% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.13% | 15.18% | -6.05% |
Volatility
PAHC vs. BSX - Volatility Comparison
Phibro Animal Health Corporation (PAHC) has a higher volatility of 13.07% compared to Boston Scientific Corporation (BSX) at 11.24%. This indicates that PAHC's price experiences larger fluctuations and is considered to be riskier than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| PAHC | BSX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.07% | 11.24% | +1.83% |
Volatility (6M)Calculated over the trailing 6-month period | 34.35% | 27.06% | +7.29% |
Volatility (1Y)Calculated over the trailing 1-year period | 52.96% | 31.28% | +21.68% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 44.84% | 24.22% | +20.62% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 43.67% | 26.76% | +16.91% |
Financials
PAHC vs. BSX - Financials Comparison
This section allows you to compare key financial metrics between Phibro Animal Health Corporation and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
PAHC vs. BSX - Profitability Comparison
PAHC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Phibro Animal Health Corporation reported a gross profit of 132.66M and revenue of 373.91M. Therefore, the gross margin over that period was 35.5%.
BSX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Boston Scientific Corporation reported a gross profit of 3.94B and revenue of 5.29B. Therefore, the gross margin over that period was 74.5%.
PAHC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Phibro Animal Health Corporation reported an operating income of 50.33M and revenue of 373.91M, resulting in an operating margin of 13.5%.
BSX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Boston Scientific Corporation reported an operating income of 1.21B and revenue of 5.29B, resulting in an operating margin of 22.8%.
PAHC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Phibro Animal Health Corporation reported a net income of 27.46M and revenue of 373.91M, resulting in a net margin of 7.3%.
BSX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Boston Scientific Corporation reported a net income of 668.00M and revenue of 5.29B, resulting in a net margin of 12.6%.